newsfilter
← Latest News
GlobeNewswire·

NeuBase Therapeutics Reports Business Update and Financial Results for the First Quarter of Fiscal Year 2023

PITTSBURGH, Feb. 14, 2023 (GLOBE NEWSWIRE) -- NeuBase Therapeutics, Inc. (NASDAQ:NBSE) ("NeuBase" or the "Company"), a biotechnology platform company Drugging the Genome™ to address disease at the base level